Search

Your search keyword '"Ancha Baranova"' showing total 15 results
Start Over Author "Ancha Baranova" Journal journal of hepatology
15 results on '"Ancha Baranova"'

2. 880 SERUM DES-ACYLGHRELIN CONCENTRATION IS ASSOCIATED WITH HISTOLOGIC NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Author

Ancha Baranova, L. Wang, Hazem Elariny, Zachary Goodman, V. Chandhoke, Z.M. Younossi, Michael Estep, Maria Stepanova, Abraham Younoszai, and G. Vernon

Subjects
medicine.medical_specialty, Hepatology, business.industry, Fatty liver, Non alcoholic, Disease, medicine.disease, Gastroenterology, Fibrosis, Internal medicine, medicine, In patient, Steatohepatitis, business
Published
2011
Full Text
View/download PDF

4. 31 VALIDATION OF A DIAGNOSTIC BIOMARKER PANEL FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH)

Author

Nila Rafiq, Mohammed Jarrar, V. Chandhoke, Z.M. Younossi, Ancha Baranova, Arian Afendy, Maria Stepanova, Clare Nugent, Zachary Goodman, Mariam Afendy, and Manpreet Randhawa

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, medicine, Diagnostic biomarker, Non alcoholic, Steatohepatitis, medicine.disease, business, Gastroenterology
Published
2008
Full Text
View/download PDF

6. 1310 EXPRESSION AND SYSTEMS BIOLOGY ANALYSIS OF T-CELL AND MACROPHAGE SPECIFIC FACTORS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Author

K. Doyle, L. Wang, Ancha Baranova, Aybike Birerdinc, R. Mehta, M. Keaton, Zachary Goodman, and Zobair M. Younossi

Subjects
Hepatology, business.industry, T cell, Systems biology, Fatty liver, Non alcoholic, Disease, medicine.disease, medicine.anatomical_structure, Immunology, medicine, Macrophage, In patient, business
Published
2013
Full Text
View/download PDF

8. 1193 ANTIGEN PROCESSING AND PROTEASOME DEGRADATION PATHWAYS ARE INVOLVED IN PATIENTS WITH CHRONIC HEPATITIS C WITH NEGATIVE PREDICTORS OF RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN (PEG-IFN/RBV)

Author

Z.M. Younossi, Issah Younossi, Ganiraju C. Manyam, Ancha Baranova, Maria Stepanova, Aybike Birerdinc, and Arian Afendy

Subjects
Hepatology, business.industry, Antigen processing, Ribavirin, Virology, chemistry.chemical_compound, chemistry, Chronic hepatitis, Pegylated interferon, medicine, In patient, Proteasome degradation, business, medicine.drug
Published
2011
Full Text
View/download PDF

9. 1352 IL28B-CC GENOTYPE-RELATED GENE EXPRESSION DURING TREATMENT OF CHRONIC HEPATITIS C (CH-C) WITH PEGYLATED INTERFERON-ALFA (PEG-IFN) AND RIBAVIRIN (RBV): POTENTIAL MECHANISMS FOR SUSTAINED VIROLOGIC RESPONSE (SVR)

Author

Z.M. Younossi, Issah Younossi, Arian Afendy, Maria Stepanova, J.M. Estep, Aybike Birerdinc, and Ancha Baranova

Subjects
chemistry.chemical_compound, Hepatology, chemistry, Chronic hepatitis, business.industry, Ribavirin, Virologic response, Genotype, Medicine, Related gene, business, Virology, Pegylated Interferon Alfa
Abstract

1352 IL28B-CC GENOTYPE-RELATED GENE EXPRESSION DURING TREATMENT OF CHRONIC HEPATITIS C (CH-C) WITH PEGYLATED INTERFERON-ALFA (PEG-IFN) AND RIBAVIRIN (RBV): POTENTIAL MECHANISMS FOR SUSTAINED VIROLOGIC RESPONSE (SVR) Z.M. Younossi, J.M. Estep, A. Birerdinc, M. Stepanova, A. Baranova, I. Younossi, A. Afendy. Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Center for the Study of Genomics in Liver Diseases, Molecular and Microbiology Department, George Mason University, Fairfax, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA E-mail: zobair.younossi@inova.org

Published
2011
Full Text
View/download PDF

10. 805 FUNCTIONAL PATHWAY ANALYSIS OF GENE EXPRESSION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH)

Author

Ganiraju C. Manyam, Maria Stepanova, Zachary Goodman, Noreen Hossain, Ancha Baranova, V. Chandhoke, and Z.M. Younossi

Subjects
medicine.medical_specialty, Hepatology, business.industry, Fatty liver, Non alcoholic, Disease, Pathway analysis, medicine.disease, Gastroenterology, Internal medicine, Gene expression, Medicine, In patient, Steatohepatitis, business
Published
2010
Full Text
View/download PDF

11. 79 SERUM CYTOKINES AND THE EXPRESSION OF MIRNAS IN THE VISCERAL ADIPOSE OF PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE

Author

Ancha Baranova, H. Elarainy, D. Armistead, V. Chandhoke, Z.M. Younossi, Maria Stepanova, Zachary Goodman, Noreen Hossain, and J.M. Estep

Subjects
medicine.medical_specialty, Cirrhosis, Hepatology, Receiver operating characteristic, business.industry, Fatty liver, Disease, medicine.disease, Gastroenterology, Liver disease, Fibrosis, Internal medicine, Cohort, medicine, Steatosis, business
Abstract

Methods: We took advantage of a previous cohort of patients explored by the Fibroscan for the validation of liver stiffness as a marker of fibrosis. Among them, a sub-group of patients was selected according to the following criteria: 1. LB and Fibroscan performed within 7 days, 2. valid Fibroscan (10 measurements), 3. LB samples ≥20mm except for patients with cirrhosis, 4. LB evaluated by two experienced pathologists (a first regular lecture for diagnosis purpose and a second lecture to quantify steatosis). 228 patients were eventually selected (64% men, mean age =48±12 years). The cause of the liver disease was HCV in 153, HBV in 21, alcohol in 30 and non alcoholic fatty liver disease in 24 patients. 35 patients had cirrhosis. Steatosis was quoted as: S0 steatosis ≤10% of hepatocytes (57% of patients), S1: 11–33% (7% of patients), S2: 34–66% (31% of patients), S3: ≥67% (6% of patients). Performance was evaluated in terms of Area Under the Receiver Operating Characteristic (AUROC). Results: Performance in terms of AUROC is summarized in the Table.

Published
2010
Full Text
View/download PDF

13. 766 A PANEL OF GENE EXPRESSION BIOMARKERS PREDICTING SUSTAINED VIROLOGIC RESPONSE (SVR) IN CHRONIC HEPATITIS C PATIENTS (CH-C) TREATED WITH PEGYLATED INTERFERON ALPHA AND RIBAVIRIN

Author

A. Bakshi, Arian Afendy, C.D. Santini, S.P. Chang, Ancha Baranova, A. Wheeler, Noreen Hossain, Maria Stepanova, A.A. Iverson, J. Chan, C.L. Sigua, and Z.M. Younossi

Subjects
medicine.medical_specialty, Hepatology, business.industry, Ribavirin, Alpha (ethology), Gastroenterology, chemistry.chemical_compound, chemistry, Chronic hepatitis, Pegylated interferon, Virologic response, Internal medicine, Gene expression, Medicine, business, medicine.drug
Published
2008
Full Text
View/download PDF

14. [718] HEPATIC MANIFESTATION OF METABOLIC SYNDROME (MS): NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND SERUM ADIPOKINES

Author

Maria Stepanova, Clare Nugent, Ancha Baranova, Rochelle Collantes, Zobair M. Younossi, Hazem Elariny, Zachary Goodman, Mohammed Jarrar, C. Bennett, V. Chandhoke, and Benjamin L. Ranard

Subjects
medicine.medical_specialty, Endocrinology, Hepatology, business.industry, Internal medicine, Fatty liver, medicine, Adipokine, Non alcoholic, Disease, Metabolic syndrome, medicine.disease, business
Published
2007
Full Text
View/download PDF

15. 724 Gene expression in hepatic and white adipose tissues of patients with obesity-related non-alcoholic steatohepatitis (NASH)

Author

Zachary Goodman, Karen Schlauch, Rochelle Collantes, V. Chandhoke, Z.M. Younossi, J.E. Ong, A. Van Meter, Shobha J Gowder, Ancha Baranova, Arian Afendy, L. Del Giacco, and H. Elarinyl

Subjects
PRDM16, medicine.medical_specialty, Hepatology, business.industry, Adipose tissue macrophages, Adipose tissue, White adipose tissue, medicine.disease, Obesity, White (mutation), Endocrinology, Internal medicine, Gene expression, medicine, Steatohepatitis, business
Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results